G. Asai

Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.

M. Seike, M. Okada, S. Morita, 2021, The Lancet. Respiratory medicine.

Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study

K. Azuma, K. Yoshimori, Satoshi Watanabe, 2020, EBioMedicine.

Balloon Dilatation of a Case of Tuberculous Tracheobronchial Stenoses during the Course of Antituberculous Treatment

M. Oki, H. Saka, C. Kitagawa, 2015, Case reports in medicine.

Is a Standard Therapy Against IIIA N2 NSCLC Induction Chemotherapy Plus Surgery

M. Endo, Toshiaki Takahashi, G. Asai, 2002 .

Pharmacokinetic and pharmacodynamic study of IST-622, a novel synthetic derivative of chartreusin, by oral administration in a phase II study of patients with breast cancer

S. Takashima, Y. Nomura, M. Toi, 2002, Cancer Chemotherapy and Pharmacology.

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.

A. Gemma, M. Okada, S. Morita, 2019, The Lancet. Oncology.

Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.

M. Fukuoka, S. Kudoh, N. Yoshimura, 2006, Anticancer research.

Influence of histological type, smoking history and chemotherapy on survival after first‐line therapy in patients with advanced non‐small cell lung cancer

Yukiko Nakamura, M. Ando, M. Endo, 2007, Cancer science.

Cyclooxygenase-2 (COX-2) inhibition with meloxicam in combination with paclitaxel and carboplatin in advanced non-small cell lung cancer (NSCLC).

N. Yamamoto, S. Ueda, G. Asai, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and Pharmacokinetic Study of Combination Chemotherapy Using Irinotecan and Paclitaxel in Patients with Lung Cancer

M. Fukuoka, K. Tamura, N. Yamamoto, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.